COCA Call – Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older

COCA Call – Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older
Visit the COCA website for a webinar link and more information

A few minutes before the webinar begins, please click the link below to join:
https://www.zoomgov.com/j/1619923732

Overview

During this COCA Call, presenters will discuss CDC’s new guidance on bivalent COVID-19 booster doses for people ages 12 years and older, including those who are moderately or severely immunocompromised. COVID-19 vaccination provides protection against serious illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death. Updated COVID-19 vaccines add an Omicron BA.4/5 spike protein component to the previous monovalent composition. These bivalent booster doses help restore protection that has waned since previous vaccination by targeting more transmissible and immune-evading variants. These boosters also broaden the spectrum of variants that the immune system is ready to respond to.

COCA Call Objectives

1. Cite background information on the topic covered during the presentation.
2. Discuss CDC’s role in the topic covered during the presentation.
3. Describe the topic’s implications for clinicians.
4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Presenters

Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Lead, COVID-19 Coordinating Unit
COVID-19 Response
Centers for Disease Control and Prevention

Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Evelyn Twentyman, MD, MPH
Lead, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention